BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Sanofi and Teva Report Positive Phase 2b Results for Duvakitug in Ulcerative Colitis and Crohn’s Disease

Primary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD), the most common forms of inflammatory bowel disease (IBD) Primary endpo...

December 18, 2024 | News

Menarini Group Reports Positive Phase 3 Results for Obicetrapib in Reducing LDL-C Levels

– Both pivotal studies achieved primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapie...

December 17, 2024 | News

Novo Holdings Completes Catalent Acquisition; Novo Nordisk Secures Strategic Manufacturing Sites

Analysis of Novo Holdings A/S’s Acquisition of Catalent and Novo Nordisk’s Strategic Expansion The imminent completion of ...

December 16, 2024 | Analysis

ADELA Phase III Trial Combines Elacestrant and Everolimus to Tackle Advanced ER+/HER2- Breast Cancer with ESR1 Mutations

ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breas...

December 13, 2024 | News

AstraZeneca and MSD LYNPARZA Shows Sustained Survival Benefit at Six Years in High-Risk Early Breast Cancer

87.5% of patients treated with LYNPARZA were alive at six years vs. 83.2% in the comparator arm First and only PARP inhibitor to improve survival in...

December 12, 2024 | News

IPO Renaissance: Biopharma's Strategic Momentum Sets the Stage for 2025

The IPO class of 2024 has redefined the biopharma and life sciences landscape, marking a return to growth after a prolonged period of market caution. These...

November 27, 2024 | Report

Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds

Life Sciences CEOs bullish on growth prospects and AI investment despite economic challenges Seventy-nine percent of life sciences CEOs are conf...

November 26, 2024 | Report

Special Report: APAC Healthcare Leaders Prioritize Sustainability Amid Global Challenges

Royal Philips , a global leader in health technology, has released the second set of findings from the Asia Pacific (APAC) Future Health Index (FHI) 2024 r...

November 26, 2024 | Report

Roche's Vabysmo Shows Promising Results in Treating Polypoidal Choroidal Vasculopathy in Asian Patients

Roche shared encouraging 16-week interim data from its ongoing Phase 3b/4 SALWEEN trial, revealing significant advancements in vision improvement and...

November 22, 2024 | News

Merck and Abbisko Report Positive Phase III Results for Pimicotinib in TGCT Across Asia, Europe, and North America

Phase III MANEUVER study met primary endpoint, with an objective response rate at week 25 of 54.0% for pimicotinib versus 3.2% for placebo (p<0.0001) ...

November 21, 2024 | News

Ascletis Completes Enrollment for Phase III Trial of ASC40 in Acne

Phase III trial enrolled a total of 480 patients with moderate to severe acne-Topline results expected in the second quarter 2025 Ascletis Pharma Inc. ann...

November 13, 2024 | News

China’s Gan & Lee’s GZR18 Injection Achieves Up to 17.8% Weight Loss in Phase 2b Trial

Obese or overweight participants receiving bi-weekly doses of 12 mg, 18 mg, 24 mg, 48 mg, and once-weekly dose of 24 mg GZR18 for 30 weeks achieved mean ...

November 12, 2024 | News

Ascletis' ASC47 Shows Promise in Phase I Trial with Once-Monthly Dosing and Superior Fat Reduction in Obesity Treatment

Data from a Phase I single ascending dose (SAD) study in Australia in subjects with elevated low-density lipoprotein cholesterol (LDL-C) showed...

November 08, 2024 | News

Powering Up Cartilage: New Mitochondrial Therapy Offers Fresh Hope for Osteoarthritis Patients

Researchers have discovered a promising new method for potentially treating osteoarthritis (OA), a debilitating joint disease for which there are currently...

November 08, 2024 | News

Stay Connected